Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige Consumer Healthcare: Rises on revenue beat

** Shares of healthcare products distributor  PBH.N  up 5.4%
at $40.97 - set for best day in 4-1/2 months
    ** PBH beats market estimates for Q1 revenue, helped by a
strong demand for products across its portfolio, which includes
Monistat women's health products and Goody's pain relievers
    ** PBH's Q1 results showed resilience in light of a
challenging selling environment - Jefferies analyst Stephanie
Wissink
    ** Company expects revenue of $225 million or more and
profit per share of 70 cents or more for Q2; both base figures
fall below Refinitiv IBES estimates  urn:newsml:reuters.com:*:nGNX8bX4PL
    ** Including session's gains, shares up ~1% this year

 (Reporting by Praveen Paramasivam in Bengaluru)
 ((Praveen.Paramasivam@thomsonreuters.com; within U.S. +1 646
223 8780 (Extn. 3478), outside U.S. +91  80 6182 3478;))

Recent news on Prestige Consumer Healthcare

See all news